20:07 , Apr 24, 2018 |  BC Extra  |  Politics & Policy

Carter introduces 340B transparency bill

Congressman Earl Carter (R-Ga.) introduced legislation Tuesday to increase transparency into the 340B drug pricing program by requiring hospitals to report low-income utilization rates for outpatient services, as well as for inpatient services in the...
08:00 , Dec 3, 2012 |  BC Week In Review  |  Company News

Bavarian Nordic, NIH, U.S. Department of Homeland Security infectious news

DHS's Science and Technology Directorate and NIH awarded Bavarian Nordic separate contracts to develop modified vaccinia Ankara (MVA) virus-based vaccines using the company's MVA-BN technology. The NIH contract, valued at up to $17.9 million, supports...
07:00 , Sep 12, 2011 |  BioCentury  |  Politics, Policy & Law

Biodefense report card

Ten years after 9/11 and the subsequent anthrax attacks alerted America to the threat posed by bioterrorism, progress in developing and procuring vaccines and drugs to protect the civilian population has been frustratingly slow. An...
07:00 , Jun 10, 2010 |  BC Innovations  |  Cover Story

Unique pathway in diabetes

A North American team has identified a proinflammatory pathway involving eukaryotic translation initiation factor 5A , a poorly understood translational initiation factor, as a potential player in diabetes. 1 Senesco Technologies Inc. , which collaborated...
07:00 , Jun 3, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

Endocrine disease Diabetes Deoxyhypusine synthase (DHPS); eukaryotic translation initiation factor 5A (EIF5A) A study in mice suggests that blocking EIF5A activity by preventing its post-translational modification with hypusine could be useful for treating type 1...
07:00 , Sep 24, 2007 |  BC Week In Review  |  Company News

Isis Pharmaceuticals, U.S. Department of Defense, U.S. Department of Homeland Security infectious, diagnostic news

ISIS's Ibis Biosciences Inc. subsidiary received three contracts from DHS totaling $3.3 million to develop methods for identifying and characterizing undisclosed bacterial and viral agents. Ibis also received a $900,000 contract from the DoD to...
07:00 , Sep 10, 2007 |  BC Week In Review  |  Company News

GenVec, U.S. Department of Homeland Security veterinary news

DHS exercised the first of two annual renewal options under a three-year contract with GNVC to develop and manufacture an adenovector-based vaccine to prevent foot-and-mouth disease, which affects animals such as cattle and swine (see...
08:00 , Feb 5, 2007 |  BC Week In Review  |  Company News

GenVec, U.S. Department of Homeland Security veterinary, infectious news

GNVC signed a three-year contract with the DHS to develop and manufacture an adenovector-based vaccine to prevent foot-and-mouth disease, which affects animals such as cattle and swine. GNVC will receive up to $6 million the...
01:12 , Jul 13, 2006 |  BC Extra  |  Politics & Policy

Senate backs personal importation

On Tuesday, the Senate voted 68-32 to pass legislation that allows U.S. citizens to import FDA-approved drugs from Canada for personal use. The bill, which was an amendment to Department of Homeland Security (DHS) spending...
08:00 , Nov 25, 2002 |  BioCentury  |  Politics, Policy & Law

Fixing one impediment to biodefense

A year after anthrax attacks on Congress and the media highlighted the nation's vulnerability to bioterrorism, the U.S. government has done little to enlist the biotech industry in efforts to develop biowar countermeasures and therapies....